TCL Archive SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped February 22, 1985
TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004